Clinical trial
Telithromycin in Acute Exacerbation of Chronic Bronchitis
NCT00288223 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00288223 |
|---|---|
| Title | Telithromycin in Acute Exacerbation of Chronic Bronchitis |
| Official title | Multicenter Non Comparative Phase IV Study on the Safety and Efficacy of Telithromycin 800 mg Per Day for 5 Days in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adults |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bronchitis, Chronic |
| Intervention type | Drug |
| Interventions | Telithromycin |
| Enrollment | 54 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Feb 7, 2006 |
| Last update posted | Dec 9, 2009 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: